ImmunityBio (IBRX) Net Margin Growth (3y) (2017 - 2026)
ImmunityBio (IBRX) Net Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 14.82 Mn |
| Sep 30, 2025 | 9.40 Mn |
| Jun 30, 2025 | 27.06 Mn |
| Mar 31, 2025 | 73.49 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 13.26 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | -27.74 Mn |
| Dec 31, 2023 | 15.86 Mn |
| Sep 30, 2023 | -7.28 Mn |
| Jun 30, 2023 | -32.52 Mn |
| Mar 31, 2023 | -970,114.00 |
| Dec 31, 2022 | 107.39 Mn |
| Sep 30, 2022 | 3.56 Mn |
| Jun 30, 2022 | -17.28 Mn |
| Mar 31, 2022 | -37.80 Mn |
| Dec 31, 2021 | -112.47 Mn |
| Sep 30, 2021 | -5.77 Mn |
| Jun 30, 2021 | 66.69 Mn |